Cerevel Therapeutics Holdings Inc (NASDAQ:CERE) traded at $41.11 at last check on Wednesday, June 12, made an upward move of 2.06% on its previous day’s price.
Looking at the stock we see that its previous close was $40.28 . In terms of its 52-week price range, CERE has a high of $43.59 and a low of $19.59. The company’s stock has lost about -2.26% over that past 30 days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Cerevel Therapeutics Holdings Inc has a market cap of $7.49 billion. Estimates by analysts give the company expected earnings per share (EPS) of -$0.61, with the EPS growth for the year raised at -$2.51 for 2024 and -$2.8 for next year. These figures represent 6.00% and -11.60% growth in EPS for the two years respectively.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the CERE stock, short term indicators assign the stock an average of 25% Sell, while medium term indicators assign it an average of Hold. Long term indicators on average place the stock in the category of 50% Buy.
Looking further, we note the current price level is -0.18% off its SMA20 and -1.61% from its 50-day simple moving average. The RSI (14) is pointing at 48.75 while the volatility over the past week is 1.50% and jumps to 1.16% over the past one month. The beta value is 1.42, while the average true range (ATR) is currently pointing at 0.52.
Coming back to Cerevel Therapeutics Holdings Inc (NASDAQ:CERE), we note that the average 3-month trading volume was 1.18 million. Current shares outstanding are 181.36 million.
The insiders hold 52.08% of the company’s shares while institutions hold 47.92%. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -3.04% down in year-to-date price movement.
